These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17545701)

  • 1. High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis.
    Mphatswe W; Blanckenberg N; Tudor-Williams G; Prendergast A; Thobakgale C; Mkhwanazi N; McCarthy N; Walker BD; Kiepiela P; Goulder P
    AIDS; 2007 Jun; 21(10):1253-61. PubMed ID: 17545701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.
    Gray GE; Urban M; Chersich MF; Bolton C; van Niekerk R; Violari A; Stevens W; McIntyre JA;
    AIDS; 2005 Aug; 19(12):1289-97. PubMed ID: 16052084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
    Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.
    Kakkar F; Lamarre V; Ducruet T; Boucher M; Valois S; Soudeyns H; Lapointe N
    BMC Infect Dis; 2014 May; 14():236. PubMed ID: 24885498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
    Church JD; Mwatha A; Bagenda D; Omer SB; Donnell D; Musoke P; Nakabiito C; Eure C; Bakaki P; Matovu F; Thigpen MC; Guay LA; McConnell M; Fowler MG; Jackson JB; Eshleman SH
    AIDS Res Hum Retroviruses; 2009 Jul; 25(7):673-7. PubMed ID: 19552593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
    JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012.
    Eshleman SH; Guay LA; Mwatha A; Brown E; Musoke P; Mmiro F; Jackson JB
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):593-7. PubMed ID: 16044013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.
    Coovadia HM; Brown ER; Fowler MG; Chipato T; Moodley D; Manji K; Musoke P; Stranix-Chibanda L; Chetty V; Fawzi W; Nakabiito C; Msweli L; Kisenge R; Guay L; Mwatha A; Lynn DJ; Eshleman SH; Richardson P; George K; Andrew P; Mofenson LM; Zwerski S; Maldonado Y;
    Lancet; 2012 Jan; 379(9812):221-8. PubMed ID: 22196945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.
    ; Arrivé E; Chaix ML; Nerrienet E; Blanche S; Rouzioux C; Coffie PA; Kruy Leang S; McIntyre J; Avit D; Srey VH; Gray G; N'Dri-Yoman T; Diallo A; Ekouévi DK; Dabis F
    AIDS; 2009 Apr; 23(7):825-33. PubMed ID: 19307941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
    JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants.
    Chiappini E; Galli L; Giaquinto C; Ene L; Goetghebuer T; Judd A; Lisi C; Malyuta R; Noguera-Julian A; Ramos JT; Rojo-Conejo P; Rudin C; Tookey P; de Martino M; Thorne C;
    AIDS; 2013 Mar; 27(6):991-1000. PubMed ID: 23211776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
    Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
    Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis.
    Nelson JA; Fokar A; Hudgens MG; Compliment KJ; Hawkins JT; Tegha G; Kamwendo DD; Kayira D; Mofolo IA; Kourtis AP; Jamieson DJ; Van Der Horst CM; Fiscus SA
    AIDS; 2015 Oct; 29(16):2131-8. PubMed ID: 26186128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening.
    Rollins N; Little K; Mzolo S; Horwood C; Newell ML
    AIDS; 2007 Jun; 21(10):1341-7. PubMed ID: 17545711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.